Dnd1 and repression of transcription in primordial germ cells

Dnd1 和原始生殖细胞转录抑制

基本信息

  • 批准号:
    8888237
  • 负责人:
  • 金额:
    $ 30.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-04-01 至 2018-12-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The germline is the only cell lineage capable of giving rise to the gametes. Defective germline development results in reduction or elimination of germ cells and ultimately causes infertility in humans, which affects 10- 15% of couples. Germ cell development begins early during embryonic development. After specification of primordial germ cells (PGCs), transcription is transiently repressed in PGCs. This is in stark contrast to the development of somatic lineages, which often relies on the activation of complex transcriptional programs. The establishment of such a transient genome-wide transcriptionally repressive state is critically important for early stages of the germline development, because it prevents PGCs from responding to surrounding signals that specify somatic cell fates. Failure to repress transcription during early stages of PGC development causes somatic differentiation and apoptosis of PGCs, which eventually leads to elimination of germ cells from the embryo. Understanding how this global transcriptionally repressive state is established in PGCs thus is highly relevant to human reproductive health. Our preliminary studies suggest that Dnd1, a RNA-binding protein required for vertebrate germ cell development, plays an essential role in establishing the genome- wide transcriptionally repressive state in PGCs. We found that Dnd1 protein is rapidly degraded by autophagy, making it intrinsically unstable. During development, Dnd1 is expressed at the right time and in the right place, and is required for the expression of Nanos1, which represses transcription in PGCs. We hypothesize that the genome-wide transcriptionally repressive state in PGCs is established through precisely regulated expression of Dnd1 protein. Specific aims are: Aim 1: To determine if Dnd1 is a central upstream regulator of the transcriptional repression in PGCs. Aim 2: To investigate the mechanisms through which Dnd1 regulates nanos1 translation. Aim 3: To determine whether autophagy- dependent Dnd1 turnover is important for the germline development.


项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jing Yang其他文献

Jing Yang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jing Yang', 18)}}的其他基金

Developing small molecule inhibitors of Pleckstrin-2 to treat thrombosis
开发 Pleckstrin-2 小分子抑制剂来治疗血栓形成
  • 批准号:
    10545992
  • 财政年份:
    2022
  • 资助金额:
    $ 30.53万
  • 项目类别:
Functional interplay between Hippo and estrogen receptor ESR1
Hippo 和雌激素受体 ESR1 之间的功能相互作用
  • 批准号:
    10573162
  • 财政年份:
    2022
  • 资助金额:
    $ 30.53万
  • 项目类别:
Apical-basal polarity in tumor progression and metastasis
肿瘤进展和转移中的顶底极性
  • 批准号:
    10468642
  • 财政年份:
    2019
  • 资助金额:
    $ 30.53万
  • 项目类别:
Apical-basal polarity in tumor progression and metastasis
肿瘤进展和转移中的顶底极性
  • 批准号:
    10228549
  • 财政年份:
    2019
  • 资助金额:
    $ 30.53万
  • 项目类别:
Maternal control of germline development
种系发育的母体控制
  • 批准号:
    10410366
  • 财政年份:
    2019
  • 资助金额:
    $ 30.53万
  • 项目类别:
2019 International EMT Society meeting
2019年国际EMT协会会议
  • 批准号:
    9914655
  • 财政年份:
    2019
  • 资助金额:
    $ 30.53万
  • 项目类别:
Maternal control of germline development
种系发育的母体控制
  • 批准号:
    10155083
  • 财政年份:
    2019
  • 资助金额:
    $ 30.53万
  • 项目类别:
Apical-basal polarity in tumor progression and metastasis
肿瘤进展和转移中的顶底极性
  • 批准号:
    10677660
  • 财政年份:
    2019
  • 资助金额:
    $ 30.53万
  • 项目类别:
Maternal control of germline development
种系发育的母体控制
  • 批准号:
    10625487
  • 财政年份:
    2019
  • 资助金额:
    $ 30.53万
  • 项目类别:
Role of integrin VLA-6 in suppression of bone formation in myeloma
整合素VLA-6在抑制骨髓瘤骨形成中的作用
  • 批准号:
    9206148
  • 财政年份:
    2016
  • 资助金额:
    $ 30.53万
  • 项目类别:

相似国自然基金

Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
  • 批准号:
    81301123
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
  • 批准号:
    81101529
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
  • 批准号:
    39500043
  • 批准年份:
    1995
  • 资助金额:
    9.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
  • 批准号:
    10719415
  • 财政年份:
    2023
  • 资助金额:
    $ 30.53万
  • 项目类别:
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
  • 批准号:
    10585802
  • 财政年份:
    2023
  • 资助金额:
    $ 30.53万
  • 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
  • 批准号:
    10605856
  • 财政年份:
    2023
  • 资助金额:
    $ 30.53万
  • 项目类别:
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
  • 批准号:
    23K08773
  • 财政年份:
    2023
  • 资助金额:
    $ 30.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
  • 批准号:
    23K15866
  • 财政年份:
    2023
  • 资助金额:
    $ 30.53万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
  • 批准号:
    10743485
  • 财政年份:
    2023
  • 资助金额:
    $ 30.53万
  • 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
  • 批准号:
    10749797
  • 财政年份:
    2023
  • 资助金额:
    $ 30.53万
  • 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
  • 批准号:
    22K09076
  • 财政年份:
    2022
  • 资助金额:
    $ 30.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
  • 批准号:
    10583516
  • 财政年份:
    2022
  • 资助金额:
    $ 30.53万
  • 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
  • 批准号:
    RGPIN-2019-05371
  • 财政年份:
    2022
  • 资助金额:
    $ 30.53万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了